Our top pick for
Guided investing
Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Biofrontera stock
Learn how to easily invest in Biofrontera stock.
Biofrontera Inc. Common Stock is a drug manufacturers-specialty & generic business based in the US. Biofrontera shares (BFRI) are listed on the NASDAQ and all prices are listed in US Dollars. Biofrontera employs 56 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Biofrontera
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BFRI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Biofrontera stock price (NASDAQ: BFRI)
Use our graph to track the performance of BFRI stocks over time.Biofrontera shares at a glance
Information last updated 2022-01-15.
| Latest market close | $4.00 |
|---|---|
| 52-week range | $2.25 - $14.63 |
| 50-day moving average | $5.61 |
| 200-day moving average | $5.53 |
| Wall St. target price | $15.50 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-2.92 |
Buy Biofrontera shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Biofrontera stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Biofrontera price performance over time
Historical closes compared with the close of $4 from 2022-01-20
| 1 week (2022-01-13) | -20.63% |
|---|---|
| 1 month (2021-12-21) | -63.74% |
| 3 months (2021-10-17) | N/A |
| 6 months (2021-07-17) | N/A |
| 1 year (2021-01-17) | N/A |
|---|---|
| 2 years (2020-01-17) | N/A |
| 3 years (2019-01-17) | N/A |
| 5 years (2017-01-17) | N/A |
Biofrontera financials
| Revenue TTM | $23.5 million |
|---|---|
| Gross profit TTM | $9.8 million |
| Return on assets TTM | 0% |
| Return on equity TTM | 0% |
| Profit margin | -99.53% |
| Book value | N/A |
| Market capitalisation | $74.5 million |
TTM: trailing 12 months
Biofrontera share dividends
We're not expecting Biofrontera to pay a dividend over the next 12 months.
Biofrontera overview
Biofrontera Inc. , a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts. .
Biofrontera in the news
Netflix quietly admits streaming competition is eating into growth
Biofrontera Inc. Issues Letter to Shareholders Highlighting 2021 Successes and Key Elements of the Strategic Plan for 2022 and Beyond
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Frequently asked questions
What percentage of Biofrontera is owned by insiders or institutions?Currently 68.966% of Biofrontera shares are held by insiders and 0.076% by institutions. How many people work for Biofrontera?
Latest data suggests 56 work at Biofrontera. When does the fiscal year end for Biofrontera?
Biofrontera's fiscal year ends in December. Where is Biofrontera based?
Biofrontera's address is: 120 Presidential Way, Woburn, MA, United States, 01801 What is Biofrontera's ISIN number?
Biofrontera's international securities identification number is: US09077D1000
More guides on Finder
-
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
-
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
-
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
-
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
-
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
-
Dogecoin jumps 10% on word you can use it to buy Tesla merch
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
-
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
-
Thursday’s top U.S. stocks: Taiwan Semiconductor Manufacturing Company Ltd. (TSM ↑8.4%), Lam Research Corporation (LRCX ↑6.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
-
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
-
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Ask an Expert